HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, M. Articles by Kovanen, P. T. Search for Related Content PubMed PubMed Citation Articles by Lee, M. Articles by Kovanen, P. T. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 975-984, June 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function

Correspondence to: Petri T. Kovanen

When stimulated, rat serosal mast cells degranulate and secrete a cytoplasmic neutral protease, chymase. We studied the fragmentation of apolipoprotein (apo) A-I during proteolysis of HDL₃ by chymase, and examined how chymase-dependent proteolysis interfered with the binding of eight murine monoclonal antibodies (Mabs) against functional domains of apoA-I. Size exclusion chromatography of HDL₃ revealed that proteolysis for up to 24 h did not alter the integrity of the -migrating HDL, whereas a minor peak containing particles of smaller size with preß mobility disappeared after as little as 15 min of incubation. At the same time, generation of a large (26 kDa) polypeptide containing the N-terminus of apoA-I was detected. This large fragment and other medium-sized fragments of apoA-I produced after prolonged treatment with chymase were found to be associated with the HDL; meanwhile, small lipid-free peptides were rapidly produced. Incubation of HDL₃ with chymase inhibited binding of Mab A-I-9 (specific for preß₁HDL) most rapidly (within 15 min) of the eight studied Mabs. This rapid loss of binding was paralleled by a similar reduction in the ability of HDL₃ to induce high-affinity efflux of cholesterol from macrophage foam cells, indicating that proteolysis had destroyed an epitope that is critical for this function. In sharp contrast, prolonged degradation of HDL₃ by chymase failed to reduce the ability of HDL₃ to activate LCAT, even though it led to modification of three epitopes in the central region of apoA-I that are involved in lecithin cholesterol acyltransferase (LCAT) activation.

This differential sensitivity of the two key functions of HDL₃ to the proteolytic action of mast cell chymase is compatible with the notion that, in reverse cholesterol transport, intactness of apoA-I is essential for preß₁HDL to promote the high-affinity efflux of cellular cholesterol, but not for the -migrating HDL particles to activate LCAT.—Lee, M., P. Uboldi, D. Giudice, A. L. Catapano, and P. T. Kovanen. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function. J. Lipid Res. 41: 975;–984.

Supplementary key words: - and preß-migrating HDL, monoclonal antibodies, LCAT, cellular cholesterol efflux, proteolysis of apoA-I

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Q. Do, S. Moshkani, P. Castillo, S. Anunta, A. Pogosyan, A. Cheung, B. Marbois, K. F. Faull, W. Ernst, S. M. Chiang, et al. Lipids Including Cholesteryl Linoleate and Cholesteryl Arachidonate Contribute to the Inherent Antibacterial Activity of Human Nasal Fluid J. Immunol., September 15, 2008; 181(6): 4177 - 4187. [Abstract] [Full Text] [PDF]

				M. Lee-Rueckert, R. Vikstedt, J. Metso, M. Jauhiainen, and P. T. Kovanen Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase J. Lipid Res., February 1, 2008; 49(2): 358 - 368. [Abstract] [Full Text] [PDF]

				P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF]

				E. Favari, M. Lee, L. Calabresi, G. Franceschini, F. Zimetti, F. Bernini, and P. T. Kovanen Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein J. Biol. Chem., March 12, 2004; 279(11): 9930 - 9936. [Abstract] [Full Text] [PDF]

				M. Lee, J. Metso, M. Jauhiainen, and P. T. Kovanen Degradation of Phospholipid Transfer Protein (PLTP) and PLTP-generated Pre-beta -high Density Lipoprotein by Mast Cell Chymase Impairs High Affinity Efflux of Cholesterol from Macrophage Foam Cells J. Biol. Chem., April 4, 2003; 278(15): 13539 - 13545. [Abstract] [Full Text] [PDF]

				M. Lee, P. T. Kovanen, G. Tedeschi, E. Oungre, G. Franceschini, and L. Calabresi Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux J. Lipid Res., March 1, 2003; 44(3): 539 - 546. [Abstract] [Full Text] [PDF]

				M. Lee, C. P. Sommerhoff, A. von Eckardstein, F. Zettl, H. Fritz, and P. T. Kovanen Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2086 - 2091. [Abstract] [Full Text] [PDF]

				M. Lee, L. Calabresi, G. Chiesa, G. Franceschini, and P. T. Kovanen Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I-Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1475 - 1481. [Abstract] [Full Text] [PDF]

				D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302. [Abstract] [Full Text] [PDF]